Atossa Therapeutics, Inc. SC 13G and SC 13G/A reports

Location
10202 5 Th Avenue Ne, Suite 200, Seattle, WA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/13/2024, 03:27 PM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report Nov 12, 2024
SC 13G Report Nov 8, 2024
SC 13G/A Report Nov 4, 2024
SC 13G Report Oct 22, 2024
SC 13G/A Report SCHEDULE 13G/A Feb 9, 2023
SC 13G Report Jul 8, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G Report SCHEDULE 13G Feb 9, 2022
SC 13G Report Feb 4, 2022
SC 13G/A Report ATOSSA THERAPEUTICS, INC. Jan 13, 2022
SC 13G Report SCHEDULE 13G Jan 15, 2021
SC 13G Report SC 13G Jan 15, 2021
SC 13G/A Report SC 13G/A Jan 15, 2021
SC 13G Report ATOSSA THERAPEUTICS, INC. Jan 14, 2021
SC 13G Report SCHEDULE 13G Dec 28, 2020
SC 13G Report SC 13G Dec 18, 2020
SC 13G/A Report AMENDMENT NO. 1 TO SCHEDULE 13G Feb 8, 2019
SC 13G Report SCHEDULE 13G Apr 27, 2018
SC 13G/A Report Feb 14, 2018
SC 13G/A Report EMPERY ASSET MANAGEMENT, LP Jan 19, 2018
SC 13G Report Nov 9, 2017
SC 13G/A Report SCHEDULE 13G Nov 3, 2017
SC 13G Report SCHEDULE 13G Nov 3, 2017
SC 13G Report ATOSSA GENETICS INC. Oct 31, 2017